Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS: NWBO · Delayed Price · USD
0.512
+0.010 (1.91%)
Apr 16, 2024, 1:53 PM EDT - Market open

Northwest Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1996
Revenue
1.931.681.011.292.410.410.340.621.741.45
Upgrade
Revenue Growth (YoY)
14.80%67.46%-22.15%-46.43%484.95%22.62%-46.07%-64.17%19.60%79.73%
Upgrade
Cost of Revenue
1.731.5520.3133.6414.1100000
Upgrade
Gross Profit
0.20.14-19.3-32.35-11.70.410.340.621.741.45
Upgrade
Selling, General & Admin
27.9833.3533.454.2616.2827.0221.519.8124.916.95
Upgrade
Research & Development
27.7335.5120.3133.6413.5918.1533.5260.08103.1285.64
Upgrade
Other Operating Expenses
-0.080.03-0.65000-2.3-5.680-18.91
Upgrade
Operating Expenses
55.7168.8653.7187.929.8745.1755.0179.89128.02102.6
Upgrade
Operating Income
-55.51-67.18-52.7-86.61-27.46-41.48-54.68-79.27-126.28-101.14
Upgrade
Interest Income
06.075.018.542.9800000
Upgrade
Interest Expense
5.536.075.018.542.989.875.553.824.151
Upgrade
Other Expense / Income
1.5637.85-236.19443.22-7.17-31.129.67-1.01-19.8551.4
Upgrade
Pretax Income
-62.6-105.03179.13-529.82-20.3-35.79-73.14-80.21-114.74-135.63
Upgrade
Income Tax
031.824.368.543.2815.563.25-1.864.15-17.91
Upgrade
Net Income
-62.6-136.85179.13-538.37-23.57-35.79-73.14-80.21-114.74-135.63
Upgrade
Shares Outstanding (Basic)
1,1191,0168747255644402431117859
Upgrade
Shares Outstanding (Diluted)
1,1191,0161,0087255644402431117859
Upgrade
Shares Change
10.17%0.79%38.99%28.53%28.22%81.19%118.63%42.93%31.17%80.28%
Upgrade
EPS (Basic)
-0.06-0.130.21-0.74-0.04-0.08-0.31-0.77-1.48-2.29
Upgrade
EPS (Diluted)
-0.06-0.13-0.06-0.74-0.04-0.08-0.31-0.77-1.48-2.29
Upgrade
Free Cash Flow
-57.07-55.68-44.31-38.7-32.22-34.78-36.5-60.59-85.36-88.3
Upgrade
Free Cash Flow Per Share
-0.05-0.05-0.04-0.05-0.06-0.08-0.15-0.55-1.10-1.49
Upgrade
Gross Margin
10.30%8.02%-1920.70%-2505.50%-485.31%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-2873.08%-3991.74%-5243.98%-6708.37%-1139.54%-10068.20%-16273.21%-12723.27%-7261.87%-6956.19%
Upgrade
Profit Margin
-3240.11%-8131.19%17823.48%-41701.39%-978.09%-8687.86%-21768.75%-12875.44%-6598.10%-9328.34%
Upgrade
Free Cash Flow Margin
-2954.14%-3308.20%-4409.35%-2997.91%-1336.89%-8441.50%-10863.99%-9725.68%-4908.51%-6073.11%
Upgrade
Effective Tax Rate
--2.44%-------
Upgrade
EBITDA
-53.78-65.65-52.76-86.18-27.46-43.47-56.54-84.76-126.23-120.04
Upgrade
EBITDA Margin
-2783.39%-3900.65%-5250.05%-6675.45%-1139.54%-10550.00%-16826.19%-13604.65%-7258.65%-8255.64%
Upgrade
Depreciation & Amortization
1.731.50.590.43-0.31.290.440.190.060.01
Upgrade
EBIT
-55.51-67.15-53.35-86.61-27.16-44.76-56.98-84.95-126.28-120.05
Upgrade
EBIT Margin
-2873.08%-3989.78%-5308.36%-6708.37%-1127.05%-10863.35%-16956.85%-13634.99%-7261.87%-8256.40%
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.